Physician profile
Catherine Stevens
NPI 1205198785
$628.32
in general payments reported to CMS, 2019-2025
13 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $34.08 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $217.07 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Horizon Therapeutics Plc | $124.99 | 2023 | Krystexxa |
| Exact Sciences Corporation | $45.50 | 2025 | The Cologuard Plus Collection Kit |
| Eisai INC. | $38.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $34.13 | 2025 | Jynarque, Rexulti |
| Lilly USA, LLC | $31.79 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $30.30 | 2025 | Breztri |
| Merck Sharp & Dohme LLC | $20.88 | 2024 | Zerbaxa, Zinplava, Dificid |
| Seqirus USA INC | $19.00 | 2025 | Flucelvax, Fluad |
| Abiomed | $18.87 | 2025 | |
| Novo Nordisk INC | $18.21 | 2025 | Wegovy |
| Esperion Therapeutics, INC. | $16.38 | 2025 | Nexletol |
| Abbvie INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.